May 29, 2019
Squarex to Present at 2019 BIO International Convention
Apr 30, 2019
FDA approves first treatment for all genotypes of hepatitis C in pediatric patients
Apr 16, 2019
NanoViricides Submits Pre-IND Briefing Documents to the US FDA
Feb 27, 2019
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
Feb 14, 2019
Squarex Announces Publication of Clinical Results for SQX770 for the Prevention of Herpes Outbreaks in Immunity, Inflammation and Disease
Feb 06, 2019
Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan
Feb 04, 2019
Cytomegalovirus Treatment Market Expected to Behold a CAGR of 6% Through 2018 - 2028
Feb 04, 2019
NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials
Jan 16, 2019
CME Outfitters Launches New Interactive Medical Simulation on Hepatitis B Virus
Jan 13, 2019
Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases
Dec 20, 2018
Squarex to Present at Biotech Showcase 2019
Dec 20, 2018
Cepheid Receives CE-IVD Clearance for Xpert® HBV Viral Load
Dec 18, 2018
Eiger Announces PRIME Designation Granted by European Medicines Agency for Lonafarnib for Treatment of Hepatitis Delta Virus Infection
Dec 17, 2018
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) Infection
Dec 14, 2018
Global Hepatitis Test Solution/Diagnosis Market to 2023 with Roche, Abbott Laboratories, Bio-Rad, Siemens, DiaSorin, QIAGEN, Danaher, bioMrieux, and Grifols Dominating
Dec 02, 2018
Merix Pharmaceutical Corp. Announces Availability of RELEEV® 1 Day Cold Sore Treatment in Convenience Stores
Nov 30, 2018
FDA authorizes first test to aid in detecting a type of herpes virus in newborns called cytomegalovirus
Nov 26, 2018
NanoViricides Files Quarterly Report for Period Ending September 30, 2018
Nov 20, 2018
Ascletis and Roche enter exclusive Pegasys partnership in China for viral Hepatitis
Oct 31, 2018
TARGET PharmaSolutions® Initiates a New Community, TARGET-HBV, to Advance the Understanding of Hepatitis B